Bank of New York Mellon’s Treace Medical Concepts TMCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $714K | Sell |
121,413
-904
| -0.7% | -$5.32K | ﹤0.01% | 3294 |
|
|
2025
Q1 | $1.03M | Sell |
122,317
-3,628
| -3% | -$30.4K | ﹤0.01% | 3040 |
|
|
2024
Q4 | $937K | Buy |
125,945
+3,215
| +3% | +$23.9K | ﹤0.01% | 3186 |
|
|
2024
Q3 | $712K | Sell |
122,730
-38,683
| -24% | -$224K | ﹤0.01% | 3312 |
|
|
2024
Q2 | $1.07M | Buy |
161,413
+18,721
| +13% | +$124K | ﹤0.01% | 3154 |
|
|
2024
Q1 | $1.86M | Sell |
142,692
-14,945
| -9% | -$195K | ﹤0.01% | 2799 |
|
|
2023
Q4 | $2.01M | Sell |
157,637
-8,713
| -5% | -$111K | ﹤0.01% | 2832 |
|
|
2023
Q3 | $2.18M | Buy |
166,350
+3,051
| +2% | +$40K | ﹤0.01% | 2765 |
|
|
2023
Q2 | $4.18M | Buy |
163,299
+39,645
| +32% | +$1.01M | ﹤0.01% | 2419 |
|
|
2023
Q1 | $3.11M | Sell |
123,654
-5,171
| -4% | -$130K | ﹤0.01% | 2552 |
|
|
2022
Q4 | $2.96M | Buy |
128,825
+27,443
| +27% | +$631K | ﹤0.01% | 2632 |
|
|
2022
Q3 | $2.24M | Buy |
101,382
+21,089
| +26% | +$465K | ﹤0.01% | 2773 |
|
|
2022
Q2 | $1.15M | Buy |
80,293
+2,641
| +3% | +$37.9K | ﹤0.01% | 3144 |
|
|
2022
Q1 | $1.47M | Buy |
77,652
+4,156
| +6% | +$78.6K | ﹤0.01% | 3095 |
|
|
2021
Q4 | $1.37M | Buy |
73,496
+41,409
| +129% | +$771K | ﹤0.01% | 3204 |
|
|
2021
Q3 | $863K | Buy |
32,087
+6,222
| +24% | +$167K | ﹤0.01% | 3474 |
|
|
2021
Q2 | $808K | Buy |
+25,865
| New | +$808K | ﹤0.01% | 3539 |
|